Elan's EL-10 for AIDS
Executive Summary
Elan's EL-10 for AIDS: First U.S. clinical trials of the oral copolymer adsorbate of DHEA began March 2 in San Francisco. A placebo-controlled trial of EL-10 is already in progress in Amsterdam, and a multi-center study proposal has been submitted to Canadian authorities, Elan said. The company obtained exclusive worldwide rights to EL-10 from microbiologist Patrick Prendergast and his company Colthurst Ltd.